Physician profile
Ali Erkin
NPI 1932603354
$1,718.30
in general payments reported to CMS, 2019-2025
10 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $452 · 2024: $367 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,393 · Education: $252 · Travel and Lodging: $73.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,393.18 |
| Education | $251.81 |
| Travel and Lodging | $73.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $679.91 | 2025 | Accolade Sr |
| Medtronic, INC. | $251.81 | 2023 | |
| Cook Medical LLC | $126.99 | 2023 | Zilver Vena |
| Inari Medical, INC. | $124.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $121.27 | 2024 | Indigo System |
| Okami Medical, INC. | $121.06 | 2024 | Lobo |
| Stryker Corporation | $119.10 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sirtex Medical INC | $78.86 | 2025 | Sir-Spheres Microspheres |
| Cook Incorporated | $73.31 | 2023 | Cook Celect |
| Trisalus Life Sciences, INC. | $21.18 | 2025 | Trinav Infusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Erkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.